Standard Biotools Inc (LAB) is a Healthcare · Medical Devices company listed on NASDAQ. Price $0.73 (+0.19%), Market cap $0.38B, 52-week low–high $0.88 ~ $1.68.
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time
Financial statements, price targets, institutional (13F) holdings and related news for Standard Biotools Inc are updated in real time on BlackAll Trade.
Standard Biotools Inc trades at $0.73 (+0.19%). Real-time quotes and charts are available on BlackAll Trade.
Standard Biotools Inc has a market cap of about $0.38B.
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop ther